Anemia and inflammation have an additive value in risk stratification of patients undergoing coronary interventions

Journal of Cardiovascular Medicine

Volumn 16, Issue 2, 2015, Pages 106-111

  Steinvil, Arie ^a,b   Rogowski, Ori ^a,b   Banai, Shmuel ^a,b   Leshem Rubinow, Eran ^a,b   Halkin, Amir ^a,b   Keren, Gad ^a,b   Finkelstein, Ariel ^a,b   Mashav, Noa ^b   Zuzut, Meital ^b   Berliner, Shlomo ^a,b   Arbel, Yaron ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

acute myocardial infraction; anemia; hemoglobin; inflammation

Indexed keywords

ANTICOAGULANT AGENT; C REACTIVE PROTEIN; HEMOGLOBIN; BIOLOGICAL MARKER;

ADVERSE OUTCOME; AGED; ANEMIA; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; TERTIARY CARE CENTER; ADVERSE EFFECTS; BLOOD; COMPLICATION; METABOLISM; MYOCARDIAL INFARCTION; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE;

ANEMIA; ANGINA PECTORIS; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE;

EID: 84920755993     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32836380b4     Document Type: Article

References (30)

1. Kurek T, Lenarczyk R, Kowalczyk J, et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2010; 105:611-618.
2. Tsujita K, Nikolsky E, Lansky A, et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010; 105:1385-1394.
3. Anker SD, Voors A, Okonko D, et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the optimaal trial. Eur Heart J 2009; 30:1331-1339.
4. Hasin T, Sorkin A, Markiewicz W, Hammerman H, Aronson D. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction. Am J Cardiol 2009; 104:486-491.
5. Aronson D, Suleiman M, Agmon Y, et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 2007; 28:1289-1296.
6. Salisbury AC, Alexander KP, Reid KJ, et al. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2010; 3:337-346.
7. James SK, Oldgren J, Lindback J, et al. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. Am Heart J 2005; 149:619-626.
8. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107:363-369.
9. Steinvil A, Banai S, Leshem-Rubinow E, et al. The development of anemia of inflammation during acute myocardial infarction. Int J Cardiol 2012; 156:160-164.
10. Schoos MM, Kelbaek H, Kofoed KF, et al. Usefulness of preprocedure highsensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention. Am J Cardiol 2011; 107:1597-1603.
11. Marechaux S, Barrailler S, Pincon C, et al. Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels 2012; 27:119-127.
12. Steinvil A, Berliner S, Shapira I, et al. Time to rheology in acute myocardial infarction: inflammation and erythrocyte aggregation as a consequence and not necessarily as precursors of the disease. Clin Res Cardiol 2010; 99:651-656.
13. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116:e148-e304.
14. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated highsensitivity C-reactive protein assay. Clin Chem 1999; 45:2136-2141.
15. Prontera C, Fortunato A, Storti S, et al. Evaluation of analytical performance of the Siemens ADVIA Tnl ultra immunoassay. Clin Chem 2007; 53:1722-1723.
16. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50:2173-2195.
17. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361:868-877.
18. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/ STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2009; 53:530-553.
19. Blanc B, Finch C, Hallberg L. Nutritional anaemias. Report of a WHO scientific group. WHO Tech Rep Ser 1968; 405:1-40.
20. Maluenda G, Lemesle G, Collins SD, et al. The clinical significance of hematocrit values before and after percutaneous coronary intervention. Am Heart J 2009; 158:1024-1030.
21. Nissenson AR, Dylan ML, Griffiths RI, Yu HT, Dubois RW. Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin. Clin J Am Soc Nephrol 2006; 1:505-510.
22. Al Falluji N, Lawrence-Nelson J, Kostis JB, et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144:636-641.
23. Nikolsky E, Aymong ED, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol 2004; 44:547-553.
24. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111:2042-2049.
25. Griffiths JD, Campbell LJ, Woodruff IW, et al. Acute changes in iron metabolism following myocardial infarction. Am J Clin Pathol 1985; 84:649-654.
26. van der Schouw YT, van der Veeken PM, Kok FJ, et al. Iron status in the acute phase and six weeks after myocardial infarction. Free Radic Biol Med 1990; 8:47-53.
27. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998; 18:555-559.
28. Nemeth E, Rivera S, Gabayan V, et al. Il-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig 2004; 113:1271-1276.
29. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009; 113:5277-5286.
30. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109:II2-II10.